Granzyme K activates protease-activated receptor-1

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Cooper, Dawn M ^a,b   Petchkovsky, Dmitri V ^a,b   Hackett, Tillie L ^a,b   Knight, Darryl A ^a,b   Granville, David J ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME; GRANZYME K; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; UNCLASSIFIED DRUG; CCL2 PROTEIN, HUMAN; THROMBIN;

ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; EXTRACELLULAR SPACE; FIBROBLAST; INFLAMMATION; LUNG; METABOLISM; PHOSPHORYLATION; SECRETION;

CELL LINE; CELL PROLIFERATION; CHEMOKINE CCL2; EXTRACELLULAR SPACE; FIBROBLASTS; GRANZYMES; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECEPTOR, PAR-1; THROMBIN;

EID: 79959711672     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021484     Document Type: Article

References (52)

1. Anthony DA, Andrews DM, Watt SV, Trapani JA, Smyth MJ, (2010) Functional dissection of the granzyme family: cell death and inflammation. Immunol Rev 235: 73-92.
2. Darrah E, Rosen A, (2010) Granzyme B cleavage of autoantigens in autoimmunity. Cell Death Differ 17: 624-632.
3. Froelich CJ, Pardo J, Simon MM, (2009) Granule-associated serine proteases: granzymes might not just be killer proteases. Trends Immunol 30: 117-123.
4. Granville DJ, (2010) Granzymes in disease: bench to bedside. Cell Death Differ 17: 565-566.
5. Hendel A, Hiebert PR, Boivin WA, Williams SJ, Granville DJ, (2010) Granzymes in age-related cardiovascular and pulmonary diseases. Cell Death Differ 17: 596-606.
6. Hiebert PR, Boivin WA, Abraham T, Pazooki S, Zhao H, et al. (2010) Granzyme B Contributes to Extracellular Matrix Remodelling and Skin Aging in Apolipoprotein E Knockout Mice. Exp Gerontol.
7. Joeckel LT, Wallich R, Martin P, Sanchez-Martinez D, Weber FC, et al. (2011) Mouse granzyme K has pro-inflammatory potential. Cell Death Differ.
8. Metkar SS, Menaa C, Pardo J, Wang B, Wallich R, et al. (2008) Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 29: 720-733.
9. Boivin WA, Cooper DM, Hiebert PR, Granville DJ, (2009) Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma. Lab Invest 89: 1195-1220.
10. Bratke K, Klug A, Julius P, Kuepper M, Lommatzsch M, et al. (2008) Granzyme K: a novel mediator in acute airway inflammation. Thorax 63: 1006-1011.
11. Rucevic M, Fast LD, Jay GD, Trespalcios FM, Sucov A, et al. (2007) Altered levels and molecular forms of granzyme k in plasma from septic patients. Shock 27: 488-493.
12. Tak PP, Kummer JA, Hack CE, Daha MR, Smeets TJ, et al. (1994) Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum 37: 1735-1743.
13. Tak PP, Spaeny-Dekking L, Kraan MC, Breedveld FC, Froelich CJ, et al. (1999) The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin Exp Immunol 116: 366-370.
14. Vernooy JH, Moller GM, van Suylen RJ, van Spijk MP, Cloots RH, et al. (2007) Increased granzyme A expression in type II pneumocytes of patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175: 464-472.
15. Bade B, Lohrmann J, ten Brinke A, Wolbink AM, Wolbink GJ, et al. (2005) Detection of soluble human granzyme K in vitro and in vivo. Eur J Immunol 35: 2940-2948.
16. Lim YP, Bendelja K, Opal SM, Siryaporn E, Hixson DC, et al. (2003) Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J Infect Dis 188: 919-926.
17. Singh K, Zhang LX, Bendelja K, Heath R, Murphy S, et al. (2010) Inter-alpha inhibitor protein administration improves survival from neonatal sepsis in mice. Pediatr Res 68: 242-247.
18. Guo Y, Chen J, Zhao T, Fan Z, (2008) Granzyme K degrades the redox/DNA repair enzyme Ape1 to trigger oxidative stress of target cells leading to cytotoxicity. Mol Immunol 45: 2225-2235.
19. Zhao T, Zhang H, Guo Y, Fan Z, (2007) Granzyme K directly processes bid to release cytochrome c and endonuclease G leading to mitochondria-dependent cell death. J Biol Chem 282: 12104-12111.
20. Zhao T, Zhang H, Guo Y, Zhang Q, Hua G, et al. (2007) Granzyme K cleaves the nucleosome assembly protein SET to induce single-stranded DNA nicks of target cells. Cell Death Differ 14: 489-499.
21. Shi L, Kraut RP, Aebersold R, Greenberg AH, (1992) A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J Exp Med 175: 553-566.
22. Bovenschen N, Quadir R, van den Berg AL, Brenkman AB, Vandenberghe I, et al. (2009) Granzyme K displays highly restricted substrate specificity that only partially overlaps with granzyme A. J Biol Chem 284: 3504-3512.
23. Irmler M, Hertig S, MacDonald HR, Sadoul R, Becherer JD, et al. (1995) Granzyme A is an interleukin 1 beta-converting enzyme. J Exp Med 181: 1917-1922.
24. Sower LE, Froelich CJ, Allegretto N, Rose PM, Hanna WD, et al. (1996) Extracellular activities of human granzyme A. Monocyte activation by granzyme A versus alpha-thrombin. J Immunol 156: 2585-2590.
25. Sower LE, Klimpel GR, Hanna W, Froelich CJ, (1996) Extracellular activities of human granzymes. I. Granzyme A induces IL6 and IL8 production in fibroblast and epithelial cell lines. Cell Immunol 171: 159-163.
26. Ossovskaya VS, Bunnett NW, (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84: 579-621.
27. Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, et al. (2005) Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26: 1-43.
28. Shpacovitch V, Feld M, Hollenberg MD, Luger TA, Steinhoff M, (2008) Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol 83: 1309-1322.
29. Reed CE, Kita H, (2004) The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 114: 997-1008; quiz 1009.
30. Akers IA, Parsons M, Hill MR, Hollenberg MD, Sanjar S, et al. (2000) Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. Am J Physiol Lung Cell Mol Physiol 278: L193-201.
31. Borensztajn K, Stiekema J, Nijmeijer S, Reitsma PH, Peppelenbosch MP, et al. (2008) Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation. Am J Pathol 172: 309-320.
32. Chambers RC, Dabbagh K, McAnulty RJ, Gray AJ, Blanc-Brude OP, et al. (1998) Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1. Biochem J 333 (Pt 1): 121-127.
33. Brousseau C, Morissette G, Fortin JP, Marceau F, Petitclerc E, (2009) Tumor cells expressing tissue factor influence the migration of smooth muscle cells in a catalytic activity-dependent way. Canadian journal of physiology and pharmacology 87: 694-701.
34. O'Brien PJ, Prevost N, Molino M, Hollinger MK, Woolkalis MJ, et al. (2000) Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. The Journal of biological chemistry 275: 13502-13509.
35. Shi X, Gangadharan B, Brass LF, Ruf W, Mueller BM, (2004) Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Molecular cancer research: MCR 2: 395-402.
36. Nakanishi-Matsui M, Zheng YW, Sulciner DJ, Weiss EJ, Ludeman MJ, et al. (2000) PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404: 609-613.
37. Deng X, Mercer PF, Scotton CJ, Gilchrist A, Chambers RC, (2008) Thrombin induces fibroblast CCL2/JE production and release via coupling of PAR1 to Galphaq and cooperation between ERK1/2 and Rho kinase signaling pathways. Mol Biol Cell 19: 2520-2533.
38. Ostrowska E, Reiser G, (2008) Protease-activated receptor (PAR)-induced interleukin-8 production in airway epithelial cells requires activation of MAP kinases p44/42 and JNK. Biochem Biophys Res Commun 366: 1030-1035.
39. Wang L, Luo J, Fu Y, He S, (2006) Induction of interleukin-8 secretion and activation of ERK1/2, p38 MAPK signaling pathways by thrombin in dermal fibroblasts. Int J Biochem Cell Biol 38: 1571-1583.
40. Pao LI, Sumaria N, Kelly JM, van Dommelen S, Cretney E, et al. (2005) Functional analysis of granzyme M and its role in immunity to infection. J Immunol 175: 3235-3243.
41. Pardo J, Simon MM, Froelich CJ, (2009) Granzyme A is a proinflammatory protease. Blood 114: 3968; author reply 3969-3970.
42. Ludwicka-Bradley A, Tourkina E, Suzuki S, Tyson E, Bonner M, et al. (2000) Thrombin upregulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C-gamma activation. Am J Respir Cell Mol Biol 22: 235-243.
43. Akira S, Kishimoto T, (1992) IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 127: 25-50.
44. Akira S, Kishimoto T, (1996) Role of interleukin-6 in macrophage function. Curr Opin Hematol 3: 87-93.
45. Ge S, Pachter JS, (2004) Caveolin-1 knockdown by small interfering RNA suppresses responses to the chemokine monocyte chemoattractant protein-1 by human astrocytes. J Biol Chem 279: 6688-6695.
46. Gharaee-Kermani M, Denholm EM, Phan SH, (1996) Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 271: 17779-17784.
47. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, et al. (2005) CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. The American journal of pathology 166: 675-684.
48. Moore BB, Peters-Golden M, Christensen PJ, Lama V, Kuziel WA, et al. (2003) Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. American journal of physiology Lung cellular and molecular physiology 284: L342-349.
49. Georganas C, Liu H, Perlman H, Hoffmann A, Thimmapaya B, et al. (2000) Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun. J Immunol 165: 7199-7206.
50. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, et al. (2005) CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166: 675-684.
51. Suga M, Iyonaga K, Ichiyasu H, Saita N, Yamasaki H, et al. (1999) Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases. Eur Respir J 14: 376-382.
52. Shinoda H, Tasaka S, Fujishima S, Yamasawa W, Miyamoto K, et al. (2009) Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration; international review of thoracic diseases 78: 285-292.